Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Arra

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivoFrancesca Bruzzese, Elena Di Gennaro, Antonio Avallone, et al.
Plos One|October 17, 2013
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cellsGabriella Castoria, Pia Giovannelli, Marzia Di Donato, et al.
Biochimica Et Biophysica Acta|May 15, 2012
Plasmacytoids dendritic cells are a therapeutic target in anticancer immunityGiuseppe Palma, Vincenzo De Laurenzi, Margot De Marco, et al.
Scientific Reports|November 23, 2016
HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanismMarco De Martino, Floriana Forzati, Marianna Marfella, et al.
International Journal of Oncology|May 9, 2014
Cripto haploinsufficiency affects in vivo colon tumor developmentEmilia Giorgio, Annamaria Liguoro, Luca D'Orsi, et al.
Biochimica Et Biophysica Acta|December 4, 2013
Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-road of pancreatic cancer cell proliferationAlessandra Dicitore, Michele Caraglia, Germano Gaudenzi, et al.
Biochimica Et Biophysica Acta|October 15, 2013
Interleukin 18: friend or foe in cancerGiuseppe Palma, Antonio Barbieri, Sabrina Bimonte, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 26, 2011
Gastrin and cholecystokinin peptide-based radiopharmaceuticals: an in vivo and in vitro comparisonAnna Lucia Tornesello, Michela Aurilio, Antonella Accardo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2013
Plasmacytoid dendritic cells play a key role in tumor progression in lipopolysaccharide-stimulated lung tumor-bearing miceAlessia Rega, Michela Terlizzi, Antonio Luciano, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma modelSilvana Morello, Rosalinda Sorrentino, Antonella Montinaro, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivoFrancesca Bruzzese, Elena Di Gennaro, Antonio Avallone, et al.
Plos One|October 17, 2013
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cellsGabriella Castoria, Pia Giovannelli, Marzia Di Donato, et al.
Biochimica Et Biophysica Acta|May 15, 2012
Plasmacytoids dendritic cells are a therapeutic target in anticancer immunityGiuseppe Palma, Vincenzo De Laurenzi, Margot De Marco, et al.
Scientific Reports|November 23, 2016
HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanismMarco De Martino, Floriana Forzati, Marianna Marfella, et al.
International Journal of Oncology|May 9, 2014
Cripto haploinsufficiency affects in vivo colon tumor developmentEmilia Giorgio, Annamaria Liguoro, Luca D'Orsi, et al.
Biochimica Et Biophysica Acta|December 4, 2013
Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-road of pancreatic cancer cell proliferationAlessandra Dicitore, Michele Caraglia, Germano Gaudenzi, et al.
Biochimica Et Biophysica Acta|October 15, 2013
Interleukin 18: friend or foe in cancerGiuseppe Palma, Antonio Barbieri, Sabrina Bimonte, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 26, 2011
Gastrin and cholecystokinin peptide-based radiopharmaceuticals: an in vivo and in vitro comparisonAnna Lucia Tornesello, Michela Aurilio, Antonella Accardo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2013
Plasmacytoid dendritic cells play a key role in tumor progression in lipopolysaccharide-stimulated lung tumor-bearing miceAlessia Rega, Michela Terlizzi, Antonio Luciano, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma modelSilvana Morello, Rosalinda Sorrentino, Antonella Montinaro, et al.
Pageof 15